135 related articles for article (PubMed ID: 38157098)
1. Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff.
Ai D; Turashvili G; Gjeorgjievski SG; Wang Q; Ewaz AM; Gao Y; Nguyen T; Zhang C; Li X
Breast Cancer Res Treat; 2024 Apr; 204(2):415-422. PubMed ID: 38157098
[TBL] [Abstract][Full Text] [Related]
2. Low interobserver agreement among subspecialised breast pathologists in evaluating HER2-low breast cancer.
Turashvili G; Gao Y; Ai DA; Ewaz AM; Gjeorgjievski SG; Wang Q; Nguyen TTA; Zhang C; Li X
J Clin Pathol; 2023 Sep; ():. PubMed ID: 37714693
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Dano H; Altinay S; Arnould L; Bletard N; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchió C; Martinez DM; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban AM; Sinke R; Stanciu-Pop CM; Stobbe C; van Deurzen CHM; Van de Vijver K; Van Rompuy AS; Verschuere S; Vincent-Salomon A; Wen H; Bouzin C; Galant C; Van Bockstal MR
Mod Pathol; 2020 Mar; 33(3):354-366. PubMed ID: 31534203
[TBL] [Abstract][Full Text] [Related]
4. Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group.
Boyaci C; Sun W; Robertson S; Acs B; Hartman J
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827609
[TBL] [Abstract][Full Text] [Related]
5. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists.
Varga Z; Diebold J; Dommann-Scherrer C; Frick H; Kaup D; Noske A; Obermann E; Ohlschlegel C; Padberg B; Rakozy C; Sancho Oliver S; Schobinger-Clement S; Schreiber-Facklam H; Singer G; Tapia C; Wagner U; Mastropasqua MG; Viale G; Lehr HA
PLoS One; 2012; 7(5):e37379. PubMed ID: 22662150
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.
Nielsen LAG; Bangsø JA; Lindahl KH; Dahlrot RH; Hjelmborg JVB; Hansen S; Kristensen BW
Diagn Pathol; 2018 Jun; 13(1):38. PubMed ID: 29885671
[TBL] [Abstract][Full Text] [Related]
7. Interobserver variability in assessing segmental function can be reduced by combining visual analysis of CMR cine sequences with corresponding parametric images of myocardial contraction.
Redheuil AB; Kachenoura N; Laporte R; Azarine A; Lyon X; Jolivet O; Frouin F; Mousseaux E
J Cardiovasc Magn Reson; 2007; 9(6):863-72. PubMed ID: 18066745
[TBL] [Abstract][Full Text] [Related]
8. Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M; Soler-Monsó T; Petit A; Azcarate J; Lasheras A; Artal C; Gil M; Falo C; Pla MJ; Matias-Guiu X
Virchows Arch; 2019 Feb; 474(2):169-176. PubMed ID: 30465110
[TBL] [Abstract][Full Text] [Related]
9. Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy.
Ginter PS; Idress R; D'Alfonso TM; Fineberg S; Jaffer S; Sattar AK; Chagpar A; Wilson P; Harigopal M
Mod Pathol; 2021 Apr; 34(4):701-709. PubMed ID: 33077923
[TBL] [Abstract][Full Text] [Related]
10. Digital breast tomosynthesis plus mammography, magnetic resonance imaging plus mammography and mammography alone: A comparison of diagnostic performance in symptomatic women.
Tang W; Hu FX; Zhu H; Wang QF; Gu YJ; Peng WJ
Clin Hemorheol Microcirc; 2017; 66(2):105-116. PubMed ID: 28211806
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience.
Røge R; Nielsen S; Riber-Hansen R; Vyberg M
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):99-104. PubMed ID: 32168036
[TBL] [Abstract][Full Text] [Related]
12. Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.
Faragalla H; Plotkin A; Barnes P; Lu FI; Kos Z; Mulligan AM; Bane A; Nofech Mozes S
Curr Oncol; 2023 Mar; 30(3):3079-3090. PubMed ID: 36975446
[TBL] [Abstract][Full Text] [Related]
13. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
[TBL] [Abstract][Full Text] [Related]
14. Laboratory validation studies in Ki-67 digital image analysis of breast carcinoma: a pathway to routine quality assurance.
Wang M; McLaren S; Jeyathevan R; Allanson BM; Ireland A; Kang A; Meehan K; Thomas C; Robinson C; Combrinck M; Harvey J; Sterrett G; Dessauvagie B
Pathology; 2019 Apr; 51(3):246-252. PubMed ID: 30850279
[TBL] [Abstract][Full Text] [Related]
15. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
[TBL] [Abstract][Full Text] [Related]
16. An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
Paulik R; Micsik T; Kiszler G; Kaszál P; Székely J; Paulik N; Várhalmi E; Prémusz V; Krenács T; Molnár B
Cytometry A; 2017 Jun; 91(6):595-608. PubMed ID: 28472544
[TBL] [Abstract][Full Text] [Related]
17. Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.
Heacock L; Lewin AA; Gao Y; Babb JS; Heller SL; Melsaether AN; Bagadiya N; Kim SG; Moy L
J Magn Reson Imaging; 2018 Jun; 47(6):1692-1700. PubMed ID: 29178258
[TBL] [Abstract][Full Text] [Related]
18. Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists.
Wu XR; Liu HS; Shi XY; Zhou WX; Jiang ZN; Huang Y; Karamchandani DM; Goldblum JR; Xiao SY; Zhu HF; Feely MM; Collinsworth AL; Esnakula A; Xie H; Shen B; Lan P; Liu XL
Gastroenterol Res Pract; 2018; 2018():8715263. PubMed ID: 29849600
[TBL] [Abstract][Full Text] [Related]
19. p16 Improves interobserver agreement in diagnosis of anal intraepithelial neoplasia.
Bean SM; Meara RS; Vollmer RT; Conner MG; Crowe DR; Novak L; Eltoum IA; Robboy SJ; Chhieng DC
J Low Genit Tract Dis; 2009 Jul; 13(3):145-53. PubMed ID: 19550211
[TBL] [Abstract][Full Text] [Related]
20. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
